Dr. Amy Brooks-Kayal is a Professor and Chair of Neurology in the School of Veterinary Medicine. Her research focuses on cellular and molecular pathways in the development of epilepsy following brain injury, with particular emphasis on identifying new therapies for the prevention and treatment of both seizures and cognitive co-morbidities characteristic of acquired epilepsy.
Dr. Marco Gonzalez is an Associate Professor of Neurology in the School of Medicine. He is interested in developing new therapies that stop or prevent recurrent seizure episodes in epilepsy. He studies cellular and molecular mechanisms underlying epileptogenesis, particularly calpain dysregulation.
Dr. Harvey is Professor in the Division of Biostatistics, Department of Public Health Sciences. Her research primarily focuses on the statistical analysis of neuroimaging data to identify markers of disease progression. Dr. Harvey assists CounterACT investigators with study design, data analysis, and preparation of presentations and manuscripts.
Dr. Brad Hobson is a Research Project Scientist at the Center for Molecular and Genomic Imaging at UC Davis. His research with the CounterACT program focuses on investigating the long term neurological consequences of acute organophosphate (OP) intoxication using in vivo imaging.
Dr. Jill Silverman is a Professor in the Department of Psychiatry and Behavioral Sciences, School of Medicine, and affiliated with the MIND Institute. She specializes in rodent cognitive behavioral assays using technology that is analogous to clinical assessment tools.
Dr. Jun Yang is a Research Scientist in the Department of Entomology and Nematology. He is an experienced analytical chemist and expert in metabolomics. His work includes analytical and data analysis methodology and metabolomics and lipidomics platform development.
Dr. Singh obtained his PhD at the Institute of Technology, Bombay (India) in organic chemistry and is an expert on the development of novel synthetic methodologies for furans, cyclohexadienones, carbohydrates, estradiol adducts and quinolones.
Donald Bruun is an Academic Program Management Officer and Lab Manager in the Department of Molecular Biosciences. Donald has focused his research on investigating novel neuroprotectants following acute exposures to organophosphates. Among his many lab skills, he has expertise in histological analyses, microscopic image acquisition, and image analysis of the brain.
Dr. Garbow is a Professor of Radiology at the Washington University School of Medicine in St. Louis, MO. He is an expert in MRI and spectroscopy methodology, including extensive preclinical MRI studies of the brain.
Dr. Fredric Gorin is a Professor Emeritus of Neurology in the School of Medicine as well as Molecular Biosciences in the School of Veterinary Medicine. He is a board-certified neurologist with training in small molecule drug design. He is interested in the relationship of the plasminogen activating system and BBB dysfunction resulting in neuroinflammation.
